Universus Photo Imagings Limited (NSE:UNIVPHOTO)
India · Delayed Price · Currency is INR 255.00
+4.65 (1.86%)
Aug 13, 2025, 3:29 PM IST
Accolade Revenue
In the fiscal year ending March 31, 2025, Universus Photo Imagings had annual revenue of 246.00M INR, down -24.25%. Universus Photo Imagings had revenue of 44.70M in the quarter ending March 31, 2025, a decrease of -53.51%.
Revenue
246.00M
Revenue Growth
-24.25%
P/S Ratio
11.35
Revenue / Employee
n/a
Employees
49
Market Cap
2.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 246.00M | -78.74M | -24.25% |
| Mar 31, 2024 | 324.74M | -107.41M | -24.86% |
| Mar 31, 2023 | 432.16M | -129.46M | -23.05% |
| Mar 31, 2022 | 561.62M | 92.02M | 19.60% |
| Mar 31, 2021 | 469.60M | -154.55M | -24.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.99B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.20B |